Purpose: To assess incidence, risk factors, and treatment of retroprosthetic membrane (RPM) formation in eyes following Boston keratoprosthesis (Kpro) implantation and their correlation with glaucoma drainage device placement (GDD).
Methods: A retrospective review was performed on eyes that underwent Kpro type I or II implantation between 2005 and 2020 at a tertiary academic center. Multiple variables were collected including preoperative characteristics, presence of RPM, management of RPM, and outcomes including corrected visual acuity (VA). A Fischer's exact test was used to evaluate the significance of risk factors of RPM formation and an odds ratio was calculated for each possible risk factor. A Mann-Whitney U test was used to evaluate comparisons between outcomes and qualitative analyses.
Results: Of the 87 eyes identified, 37 (43%) developed an RPM within an average of 1.5 years (range, 31 days-7.5 years) following Kpro implantation. Mean follow-up duration was 4.3 years. Eyes that developed RPM had significantly worse preoperative VA compared to those that did not (logMAR 2.55 vs. 2.28, p = 0.022). The mean number of prior penetrating keratoplasty procedures trended higher in eyes that developed RPM (2.46 vs. 2.18, p = 0.44) but was not significant. GDD placement after Kpro implantation was associated with an increased risk of RPM formation (RR = 1.69 p = 0.026). Of the 37 eyes that developed an RPM following Kpro, 17 (47%) were treated with Nd:YAG laser, and four of those 17 (21%) also underwent pars plana vitrectomy (PPV). Seven of 37 eyes (19%) underwent PPV without Nd:YAG. Comparisons between RPM occurrence and final VA were not significant.
Conclusions: The incidence of RPM formation following Kpro implantation was 43%. Eyes that developed RPM had significantly worse preoperative VA. GDD placement after Kpro implantation increased the risk of developing RPM. Final VA and occurrence of RPM were not significantly different between the Nd:YAG and PPV treatment groups.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00417-024-06445-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Vision-Related Quality of Life After Fyodorov-Zuev Keratoprosthesis in China.
Cornea
November 2024
Department of Ophthalmology, The Third Medical Center of People's Liberation Army General Hospital, Beijing, China.
Purpose: The purpose of this study was to assess vision-related quality of life (VR-QoL) and its determinants in patients with implanted Fyodorov-Zuev (MICOF) KPro.
Methods: Eighty-eight patients with bilateral corneal blindness who underwent unilateral Fyodorov-Zuev (MICOF) KPro implantation were included in this cross-sectional study. VR-QoL was assessed using the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25).
Visual outcomes of primary keratoprosthesis implantation in transplant-naïve eyes.
PLoS One
October 2024
Department of Ophthalmology, Duke University School of Medicine, Durham, North Carolina, United States of America.
Article Synopsis
- * A review of data from 2005 to 2020 identified 84 eyes from 77 patients, with 12 eyes being corneal transplant-naïve and receiving primary Kpro.
- * Results show that visual acuity outcomes were similar for both primary and secondary Kpro, though primary Kpro patients tended to have slightly better visual acuity at the final follow-up, with no significant differences in complications like glaucoma or retinal detachment between the two groups.
Clinical Outcomes of Stage 2 (Pivotal) Use of a Modified Keratoprosthesis Device (ORC-KPro) in Patients with End-stage Corneal Blindness.
J Ophthalmic Vis Res
September 2024
Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Article Synopsis
- The study aimed to evaluate the short-term outcomes of a modified Boston keratoprosthesis device (ORC-KPro) in patients suffering from end-stage corneal blindness.
- It included 12 patients (mostly middle-aged and male) where corneal blindness was primarily due to chemical burns or previous graft failures, achieving anatomical success for all cases.
- While most patients experienced improved vision post-surgery, functional success was restricted because of underlying severe eye conditions, impacting overall visual potential.
Results of Lucia Keratoprosthesis Implantation in Severe Corneal Disease.
Am J Ophthalmol
December 2024
From the Instituto de Oftalmologia Fundacion Conde de Valenciana IAP (G.O.-M., G.R.V.-D., D.J.-C., J.A.R., K.A.R., J.L.D.-H., C.A.M.-M., A.N., A.R.-M., E.O.G.-H.), Mexico City, Mexico. Electronic address:
Purpose: Describe complications, functional success, and retention of the Lucia Keratoprosthesis (KPro).
Design: Retrospective interventional case series METHODS: The demographic data, baseline characteristics, complications, functional success, and retention were analyzed for Lucia KPro at the Instituto de Oftalmologia Conde de Valenciana in Mexico City from 2021 to 2023. Multivariate regression analysis and Kaplan-Meier plots were performed to identify associations with functional failure.
Visual restoration with KPro after face allotransplantation with a grade III phthisical eye.
Digit J Ophthalmol
July 2024
Retina Service and Cornea Service, Department of Ophthalmology, Mass Eye and Ear, Mass General Brigham Harvard Medical School, Boston, Massachusetts.
The Boston Keratoprosthesis type I (KPro-I) has been shown to be successful in restoring vision after severe ocular burns; however, its long-term outcomes in phthisical eyes have rarely been reported. A monocular woman with a history of severe alkali chemical injury necessitating facial transplantation presented with a light perception left eye after a complicated course, including failed KPro-I, therapeutic penetrating keratoplasty, endophthalmitis, hypotony, total retinal detachment, and structural changes, including a shrunken 18 mm axial length and eye wall thickening. The patient underwent a combined vitrectomy with silicone oil and KPro-I implantation, resulting in her regaining ambulatory visual acuity (20/250) at 3 years' follow-up
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!